Sign in
CompletedEarly phase 1

Effect of a Novel Intervention Using Daily Intermittent Hypoxia and High Intensity Training on Upper Limb Function in Individuals With Spinal Cord Injury

Key facts

Who runs it
Shirley Ryan AbilityLab
Where
Chicago, United StatesSee the site
Trial code
Status
Completed
Phase
Early phase 1
People taking part
58 people enrolled
Started
16 Nov 2018
Ended
30 Jun 2025
Type of study
Interventional, 4 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Upper extremity training/Armeo Spring
Record updated
2 December 2025

Who can take part

Age
18 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (17)Hide the full registry criteria

Who can take part

  • History of a non-progressive spinal cord injury, inclusive of levels of C1-T1
  • Etiology of spinal cord injury is non-progressive in nature
  • Be able to demonstrate some hand muscle activation, or use of a tenodesis grasp (wrist extension)
  • At least 6 months post injury
  • Participants do NOT have to stop taking antispasticity medications to participate in the study
  • Must be tested for anemia with a value of at least 10g/dl (for both men and women)
  • Patients will be recommended to their primary care physician to correct anemia if low levels are detected
  • Blood pressure must fall within this range- high: 160/110mmHg low: 85/55 mmHg
  • Must be asymptomatic (no dizziness, lightheadedness, etc)

Who cannot take part

  • Medical conditions, including: congestive heart failure, cardiac arrhythmias, uncontrolled hypertension, uncontrolled diabetes mellitus, chronic obstructive pulmonary disease, emphysema, severe asthma, previous myocardial infraction, or known carotid/intracerebral artery stenosis
  • Concurrent participation in another research study or therapy services
  • Women who are currently pregnant or planning on becoming pregnant
  • Current tracheostomy placement
  • Utilization of mechanical ventilator for breathing
  • Current diagnosis of obstructive sleep apnea
  • Orthopedic injuries or surgeries that would limit participation
  • Comorbid traumatic brain injury or other neurologic injuries that would impact cognition

Where in United States

  • Shirley Ryan AbilityLabChicago, United States

About the trial

What the trial wants to find out

Currently, there are a variety of approaches utilized in attempts to improve upper extremity function, including: traditional therapy, neuroprostheses, botulinum toxin injections, or surgical interventions. In addition, regenerative and restorative therapies, such as: epidural stimulation, functional electrical stimulation, and stem cell therapies, show promise in animal models, but are not ready for clinical translation. Subsequently, there is a clear need to develop new strategies that can stimulate spinal plasticity and strengthen existing synaptic connections in order to maximize the benefits of training paradigms.

Read full original descriptionShow less

This study proposes the examine the effects of Acute Intermittent Hypoxia (AIH) in combination with upper extremity training, over the course of a month, to evaluate changes in upper extremity function, dexterity, and ability to complete activities of daily living. The use of acute intermittent hypoxia (AIH) has been demonstrated, through human and animal studies, to be an effective way of increasing spinal motor excitability and strengthening residual synaptic connectivity. AIH utilizes short duration (<2 min) exposures to reduced oxygen levels (~10% inspired oxygen), with alternating exposures to air with normal oxygen levels (~21% inspired oxygen).

Previous publications demonstrate that AIH is a safe and effective intervention to modify motor function in individual with chronic incomplete spinal cord injuries. The use of AIH has been shown to influence the activation in musculature, within 60-120 minutes of administration. In addition, when coupling AIH with overground gait training, an increase in functional endurance, as evaluated through the 6 minute walk test, and gait speed, as evaluated through the 10 meter walk test, were demonstrated. In addition, the use of hypoxic training has been studied in healthy individuals and athletes; however, literature examining the effect of a single bout of AIH on performance is limited.

The 4 groups in the trial

  • Acute Intermittent Hypoxia (AIH) treatmentNo study treatment, for comparison

    The mask will first provide a normoxic air (room air) mixture (FiO2 = 0.21) via the mask. The mask is designed to couple with a universal mask circuit connecting to the air mixture system. The purpose of the mask will be to minimize room air entrainment.

  • AIH in combination with upper extremity trainingExisting treatment, for comparison

    The mask will first provide a normoxic air (room air) mixture (FiO2 = 0.21) via the mask. The mask is designed to couple with a universal mask circuit connecting to the air mixture system. The purpose of the mask will be to minimize room air entrainment. In addition to this upper extremity training will be given using an upper-limb robotic rehabilitation device.

    Treatment: Upper extremity training/Armeo Spring

  • Sham AIH therapy in combination with upper extremity trainingExisting treatment, for comparison

    Sham hypoxia followed by upper extremity training will be given using an upper-limb robotic rehabilitation device (Armeo Spring®, Hocoma AG, Switzerland). Armeo Spring is a gravity support system based on an ergonomic arm exoskeleton with integrated springs.

    Treatment: Upper extremity training/Armeo Spring

  • Sham AIH therapyNo study treatment, for comparison

    Sham hypoxia

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
2 December 2025